July 11, 2017
In Monday’s Joint ISTH-WFH State-of-the-Art Session, “Novel Functions of VWF”, Stefan Schneider, M.D. discussed the role of von Willebrand Factor (VWF) in coagulation and its link to cancer
Read More
July 10, 2017
During Monday’s ISTH 2017 Abstract Symposia Session, ISTH President Johannes Oldenburg, M.D., Ph.D., presented results from the pivotal HAVEN 1 clinical trial.
Read More
July 10, 2017
Congratulations to the winners of the 2017 Journal of Thrombosis and Haemostasis Editors’ Awards. Five young first authors of these papers received a travel grant to attend the Congress.
Read More
July 10, 2017
During Monday’s Oral Session of Hemorrhagic Disorders: Pediatric Aspects, Guy Young, M.D. presented interim results from the pivotal HAVEN 2 clinical trial.
Read More
July 10, 2017
Luis Jara-Palomares, M.D., Ph.D. presented the results of the external validation of this prognostic score using the RIETE database in a subsequent cohort of patients.
Read More
July 10, 2017
A prediction score to identify VTE patients at increased risk of an occult cancer diagnosis was recently proposed. At yesterday’s Cancer Associated Thrombosis: Risk Prediction Oral Session, Nick van Es, M.D. presented the results of an analysis testing this score across several metrics.
Read More